24 November 2020 - The EMA could produce a scientific opinion on COVID-19 vaccines seeking regulatory approval by the end of the year in a best case scenario, the regulator’s new chief was quoted as saying on Tuesday.
British drugmaker AstraZeneca followed rivals Pfizer and Moderna on Monday in publishing successful pivotal trial data for its COVID-19 vaccine, giving the world’s fight against the pandemic a third new weapon.